Carola Metzig

2.8k total citations
16 papers, 723 citations indexed

About

Carola Metzig is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Carola Metzig has authored 16 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Carola Metzig's work include Retinal Imaging and Analysis (12 papers), Retinal Diseases and Treatments (12 papers) and Retinal and Optic Conditions (10 papers). Carola Metzig is often cited by papers focused on Retinal Imaging and Analysis (12 papers), Retinal Diseases and Treatments (12 papers) and Retinal and Optic Conditions (10 papers). Carola Metzig collaborates with scholars based in Germany, United States and Italy. Carola Metzig's co-authors include Jeffrey I. Weitz, Scott D. Berkowitz, Gary E. Raskob, Michael R. Lassen, Rupert Bauersachs, Maria Cecília S. Freitas, Gilles Edan, Xavier Montalbán, Ludwig Kappos and Rupert Sandbrink and has published in prestigious journals such as JAMA, The Lancet Neurology and Ophthalmology.

In The Last Decade

Carola Metzig

15 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carola Metzig Germany 10 324 194 184 124 121 16 723
Cordula Fassbender Germany 16 79 0.2× 87 0.4× 77 0.4× 28 0.2× 212 1.8× 36 592
Alberto Floris Italy 16 172 0.5× 40 0.2× 99 0.5× 98 0.8× 99 0.8× 51 854
P Meyer United Kingdom 14 77 0.2× 202 1.0× 143 0.8× 28 0.2× 57 0.5× 25 552
Junjun Zhang China 17 63 0.2× 302 1.6× 157 0.9× 66 0.5× 43 0.4× 46 879
Hirotomo Tanaka Japan 13 140 0.4× 86 0.4× 24 0.1× 211 1.7× 198 1.6× 35 611
Giuseppe Paolazzi Italy 16 33 0.1× 183 0.9× 31 0.2× 141 1.1× 59 0.5× 46 851
Daniel J. Wallace United States 6 114 0.4× 34 0.2× 184 1.0× 37 0.3× 51 0.4× 9 896
Jun Kikuchi Japan 13 59 0.2× 26 0.1× 67 0.4× 40 0.3× 88 0.7× 66 594
Riri S. Manor Israel 13 71 0.2× 232 1.2× 42 0.2× 39 0.3× 100 0.8× 41 515
Chunde Li China 15 70 0.2× 37 0.2× 54 0.3× 327 2.6× 146 1.2× 91 888

Countries citing papers authored by Carola Metzig

Since Specialization
Citations

This map shows the geographic impact of Carola Metzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carola Metzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carola Metzig more than expected).

Fields of papers citing papers by Carola Metzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carola Metzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carola Metzig. The network helps show where Carola Metzig may publish in the future.

Co-authorship network of co-authors of Carola Metzig

This figure shows the co-authorship network connecting the top 25 collaborators of Carola Metzig. A scholar is included among the top collaborators of Carola Metzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carola Metzig. Carola Metzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Weitz, Jeffrey I., Rupert Bauersachs, Scott D. Berkowitz, et al.. (2020). Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty. JAMA. 323(2). 130–130. 183 indexed citations
2.
Wykoff, Charles C., Chirag P. Shah, Dilsher S. Dhoot, et al.. (2019). Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study. Ophthalmology. 126(8). 1171–1180. 30 indexed citations
3.
Ali, Ferhina S., Namrata Saroj, Keith Baker, et al.. (2019). Impact of Posterior Vitreous Detachment on Treatment Outcomes in Diabetic Macular Edema. Ophthalmology Retina. 4(4). 452–454.
4.
Mitchell, Paul, Michael Larsen, Giovanni Staurenghi, et al.. (2018). Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies. Ophthalmology Retina. 2(10). 988–996. 44 indexed citations
5.
Terasaki, Hiroko, Kunihiko Shiraki, Masahito Ohji, et al.. (2018). EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN. Retina. 39(5). 938–947. 6 indexed citations
6.
Midena, Edoardo, et al.. (2018). Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies. Journal of Ophthalmology. 2018. 1–9. 7 indexed citations
7.
Dhoot, Dilsher S., Keith Baker, Namrata Saroj, et al.. (2017). Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema. Ophthalmology. 125(1). 51–56. 42 indexed citations
8.
Singh, Rishi P., Charles C. Wykoff, David M. Brown, et al.. (2017). Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c. Ophthalmology Retina. 1(5). 382–388. 9 indexed citations
9.
Pieramici, Dante J., Rishi P. Singh, Andrea Gibson, et al.. (2017). Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID Studies. Ophthalmology Retina. 2(6). 558–566. 22 indexed citations
10.
Staurenghi, Giovanni, Nicolas Feltgen, Jennifer Arnold, et al.. (2017). Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies. British Journal of Ophthalmology. 102(7). 954–958. 15 indexed citations
11.
Wykoff, Charles C., Dennis M. Marcus, Edoardo Midena, et al.. (2016). Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema. JAMA Ophthalmology. 135(2). 107–107. 9 indexed citations
12.
Ogura, Yuichiro, Nicolas Feltgen, Jean‐François Korobelnik, et al.. (2015). Effect of Baseline Central Retinal Thickness (CRT) and Best Corrected Visual Acuity (BCVA) on Treatment Outcomes With Intravitreal Aflibercept Injection (IAI) or Macular Laser Photocoagulation in Diabetic Macular Edema (DME). 56(7). 1748–1748. 1 indexed citations
13.
Staurenghi, Giovanni & Carola Metzig. (2015). Intravitreal Aflibercept (IVT‐AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID‐DME and VISTA‐DME. Acta Ophthalmologica. 93(S255). 1 indexed citations
14.
Maurer, Britta, Nicole Graf, Beat A. Michel, et al.. (2014). Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Annals of the Rheumatic Diseases. 74(6). 1124–1131. 87 indexed citations
15.
Metzig, Carola, Ludwig Kappos, CH Polman, et al.. (2011). Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis. Multiple Sclerosis Journal. 18(7). 966–973. 10 indexed citations
16.
Kappos, Ludwig, Mark S. Freedman, Chris H. Polman, et al.. (2009). Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. The Lancet Neurology. 8(11). 987–997. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cordula Fassbender Breakdown of academic impact, for papers by Alberto Floris Breakdown of academic impact, for papers by P Meyer Breakdown of academic impact, for papers by Junjun Zhang Breakdown of academic impact, for papers by Hirotomo Tanaka Breakdown of academic impact, for papers by Giuseppe Paolazzi Breakdown of academic impact, for papers by Daniel J. Wallace Breakdown of academic impact, for papers by Jun Kikuchi Breakdown of academic impact, for papers by Riri S. Manor Breakdown of academic impact, for papers by Chunde Li
Rankless by CCL
2026